Mastek share news, announcements and annual reports
NSE: MASTEKBSE: 523704IT - SoftwareSmall Cap
Mastek Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1993 on BSE, May 1995 on NSE
Last close ₹1,429.60down ₹44.40 (3.01%)BSE ₹1,428.90
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,474.00.
30 Oct: open ₹1,480.70, high ₹1,499.00, low ₹1,411.00
52-week range of traded prices to 30 Oct 2026
₹1,334.20Low, 30 Mar 2026₹2,369.00High, 17 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,433 Cr757th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 10.40
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.39
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.68%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.11
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,94,79951.5% delivered
Mastek share news and announcements
1,515 announcements, routine notices left out, newest first. Page 24 of 31.
Jul 2014
May 2014
27 May · Meeting Updates
Nomination and Remuneration Committee of the Board of Directors at its meeting held on May 23, 2014, granted 1,383,207 stock options (ESOP's) to the eligible employees. The terms and conditions of the said ESOP's are as under: 1. Out of the above 1,052,000 options are granted at the market price of Rs. 179/- per share and the balance 331,207 options are granted at a price of Rs. 5/- per share. 2. On exercise of the option, one equity share of face value of Rs. 5/- each shall be allotted per option. 3. The options shall vest at the rate of 25% at the end of each year from the date of grant. 4. The first option shall vest only after a period of twelve months from the date of grant. 5. The vested options can be exercised within a period of seven years from the date of vesting.
Apr 2014
28 Apr · Meeting
Company has fixed Book Closure from July 08, 2014 to July 15, 2014 (both days inclusive) for the purpose of declaring dividend and for holding Annual General Meeting scheduled to be held on July 23, 2014.23 Apr · Dividend
Board of Directors of the Company at its meeting held on April 23, 2014 have recommended final dividend @ Rs 2.75/- per share (55%) for approval of the Shareholders at the ensuing Annual General Meeting which if approved will be paid on or after July 28, 2013 and before August 21, 2014.23 Apr · Board meeting
15 Apr · Board meeting
To consider and take on record inter alia the following: 1. Audited Financial Results of Company on Stand-Alone basis and Consolidated Financial Results for the Year Ended March 31, 2014 together with the report of Directors and Auditors thereon; 2. To consider and recommend payment of Final dividend on the equity shares, if any; 3. To Fix the Book Closure Dates; 4. To fix the day, date, time and place of Annual General Meeting of the Company
Mar 2014
21 Mar · Updates
Draft of the resolution along with necessary papers for closure of Buyback Offer of the Company will be circulated to the Board of Directors on March 21, 2014 for their approval and the closure date would be intimated to the Stock Exchanges on receipt of their approval.
Feb 2014
19 Feb · Board meeting
To consider the result of Postal Ballot for Buyback of shares of the Company and matters incidental thereto.
Jan 2014
15 Jan · Board meeting
Inter alia to consider and take on record the Unaudited Financial Results for the quarter ended on December 31, 2013.9 Jan · Buyback
Board of Directors of the Company at their meeting held on January 08, 2014 has decided on Buy-Back of Company's equity shares of Rs.5/- each from open market through stock exchange mechanism in accordance with the provisions of Section 77A, 77B(2) of the Companies Act, 1956, Section 69, 70(1) of the Companies Act, 2013 read with Securities and Exchange Board of India (Buyback) Regulations, 1998 and amendments thereto till date, at a price not exceeding Rs.250/- per equity share payable in cash for an aggregate amount not exceeding Rs.5,450 lakhs for buyback of maximum of 32,00,000 equity shares and minimum of 9,50,000 equity shares. The offer size represents 14.92% of the aggregate of the Company's paid up equity capital and free reserves as on March 31, 2013. The buyback will be implemented with the approval of the shareholders of the Company by way of a Special Resolution through postal ballot and all other applicable statutory approvals.3 Jan · Board meeting
To consider a proposal of buyback of equity shares of the Company.
Dec 2013
31 Dec · Business
At the meeting of the Share Transfer, Investor Grievances and Stakeholder Relationship Committee held on.December 31, 2013, 6,500 equity shares of Rs.5/- each ( face value) have been allotted on exercise of 6,500 stock options at a price of Rs. 92/-per share, being the price of grant. Resultantly the Paid up Share Capital of the Company stands increased to 2,46,44,687 equity shares amounting in aggregate to Rs.12,32,23,435.26 Dec · Legal
We refer to our letter dated December 20,2013. We also refer to the statements made during the Program broadcasted by CNBC Awaz at 8.21 am on December 20, 2013 and the news published on December 24, 2013 on the website of The Economic Times regarding stake sale in the Company. We would like to clarify that there is no development in respect of the any stake sale by the Promoters of the Company and they have confirmed that they do not have any intention of selling their stake in the Company.20 Dec · Updates
Vide letter dated December 20, 2013 that : "We have observed that the share price of Mastek Ltd has sharply increased with very high volumes in the first hour of trade today. We are very much concerned about the above activity. We would like to clarify to your goodselves that there is no development in Mastek Ltd to warrant such volatility in the share price".
Nov 2013
15 Nov · Updates
Major North American customer is reprioritizing its multi-vendor transformation program. While the company is yet to receive an official intimation from the client, the replanning by the customer is likely to result in the work being put on hold and as a result impact the revenue of the North American business. the company is engaged in discussions with the customer to better understand their plans and the impact of the pending changes on our plans- a clear picture is expected to emerge in next six to eight weeks. the company continue to have a strong relationship with the customer and our solution continues to have customer's confidence. Mastek continues to see good momentum in its insurance business in North America and is expecting key wins in the next few months.
Oct 2013
25 Oct · Dividend
Dividend will be paid on or after November 07, 2013 and before November 23, 2013.25 Oct · Dividend
Board of Directors of the Company at its meeting held on October 24, 2013 has approved payment of Interim dividend @ Rs 1.75/- per share(35%).25 Oct · Board meeting
Board of Directors of the company at their meeting held on October 24, 2013:(1). Appointed Dr. Arun Maheshwari as an Additional Director of the Company. Dr.Maheshwari holds Master's degree in Computer Science from Stanford University, an MBA from Columbia University and a Ph.D. from Wharton School of Business and has studied at IIM, Calcutta. Dr. Maheshwari served Tata Consultancy Services (TCS), as a senior executive responsible for marketing, software development, and management consulting for three years after which he joined McKinsey, in New York, USA in 1977. At McKinsey, he specialized in Strategy and Information Technology studies, many of them in the Insurance industry. Dr. Maheshwari also worked for Continental Insurance (now CNA), as a Senior Information Technology Executive. During his career at Continental, he made a transition from IT to Finance and was responsible for all accounting and back office functions. In 1996, Dr. Maheshwari started CSC India which grew rapidly and received many awards, including Best Employer Award in India. He is currently associated with FirstMark private equity group. He has served as a Board member for Duck Creek Technologies (recently sold to Accenture) and is currently a Board member of Eagle Eye Analytics. He is also a director of Fortegra; a NYSE listed insurance product and Services Company.11 Oct · Corporate action
Company has fixed Record Date as November 06, 2013 for the purpose of payment of interim Dividend which would be declared at their Board Meeting to be held on October 24, 2013.7 Oct · Board meeting
To consider inter alia the following: 1. To consider and take on record the unaudited Financial Results for the quarter & half year ended September 30, 2013. 2. To consider the proposal for payment of Interim dividend for the financial year ending March 31, 2014. 3. To fix the record date and bankers for the payment of Interim dividend. 4. To consider appointment of Mr. Arun Maheshwari as an Additional Director. 5. Any Other matter with the permission of Chair.
Sep 2013
Jul 2013
24 Jul · Board meeting
With reference to the earlier announcement dated July 19, 2013, regarding outcome of Compensation Committee Meeting, Mastek Ltd has now informed Exchange that there was a typographical error in mentioning the date of Compensation Committee Meeting as July 18, 2013 instead of July 19, 2013. Therefore, the Date of Compensation Committee Meeting should be read as July 19, 2013.19 Jul · Disclosure
Compensation Committee of the Board of Directors at its meeting held on July 19, 2013, granted 55000 Stock Options (ESOP's) to the eligible employees. The terms and conditions of the said ESOP's are as under : (1) The Options are granted at the market price of Rs. 140/- per share; (2) On exercise of the option, one equity share of face value of Rs. 5/- each shall be allotted per option; (3) The Options shall vest at the rate of 25% at the end of each year from the date of grant; (4) The first option shall vest only after a period of twelve months from the date of grant; (5) The vested options can be exercised within a period of seven years from the date of vesting.19 Jul · Board meeting
Board of Directors of the Company at its meetings held on July 19, 2013: (1) Approved ESOP Plan VII as per terms approved by Shareholders at their Annual General Meeting held on July 17, 2013 and Compensation Committee Meeting held on July 18, 2013.